A breakthrough anti-viral drug found to help critically-ill patients recover from coronavirus within a week is not part of a drug trial run by the University of Oxford to find a treatment, it has emerged. The drug remdesivir, manufactured by pharmaceutical giant Gilead Sciences, has been undergoing trials in the US and smaller trials in the UK run … Read more
More than 5,000 people in Britain have volunteered to take part in a pioneering drug trial in search of a treatment for the currently incurable COVID-19. The Recovery Trial, conducted by Oxford University, recruited the participants — all of whom are COVID-19 patients already in hospital — at more than 160 NHS hospitals. Participants will … Read more
Remdesivir anti-viral trial reports ‘rapid recoveries’ for severe hospitalised coronavirus patients with ‘nearly all’ discharged within a week. University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients were been treated with daily infusions of remdesivir. Most of them … Read more
The first results from an international experimental US antiviral drug are promising, even as a trial of the same drug in China shuts down. More than half of a group of severely ill coronavirus patients from the US, Canada, Europe and Japan improved after taking remdesivir made by California-based Gilead Sciences. Originally developed as a … Read more
Scientists in Brazil have stopped part of a study of a malaria drug touted as a possible coronavirus treatment after heart rhythm problems developed in one-quarter of people given the higher of two doses being tested. Chloroquine and a newer, similar drug called hydroxychloroquine, have been pushed by President Donald Trump after some early tests … Read more
A pharmaceutical firm will donate two million antimalarials to the world’s largest COVID-19 medication trial following Donald Trump’s praise of the drug. Accord Healthcare Ltd, a global medicine distributor, will supply hydroxychloroquine to 40,000 frontline healthcare workers in the COPCOV study. They will take a hydroxychloroquine tablet daily and be followed for a five-month period to … Read more
Scientists are set to begin testing anti-malarial drugs on 40,000 healthcare workers in Africa, Europe, and Asia that could help prevent nurses and doctors from becoming infected with coronavirus A drug trial will test two anti-malarial as preventative coronavirus drugs It will include 40,000 healthcare workers from across the world If effective, the drugs could help … Read more
Etihad to trial monitoring technology fitted to airport self-service points that may be able to identify passengers with coronavirus The machines have been developed with Australian firm Elenium Automation They will monitor passengers’ temperatures, and heart and respiratory rates New technology will be trialled this month at Etihad’s hub airport in Abu Dhabi By Jennifer … Read more
Second US coronavirus vaccine trial which was given funding by Bill Gates launches in Pittsburgh and Kansas City as drug company promises 1 million doses of its shot by year-end Inovio Pharmaceuticals announced Monday that it has begun recruiting volunteers for its coronavirus vaccine trial The company will enroll 40 healthy subjects in Pittsburgh, Pennsylvania, … Read more
‘Quarantine day 421’: Jussie Smollett returns to Instagram with a soulful song… as he awaits trial for ‘hoax’ race attack in Chicago By Deirdre Simonds For Dailymail.com Published: 19:06 GMT, 25 March 2020 | Updated: 19:06 GMT, 25 March 2020 Jussie Smollett has reemerged on Instagram with a soulful song, as he awaits trial for … Read more